Articles of interest – International Liver Cancer Association

Direct acting antiviral for hepatitis C after treatment of hepatocellular carcinoma

Gastroenterology, May 2019

Biomarkers associated with response to regorafenib in patients with hepatocellular carcinoma

Gastroenterology, May 2019

Somatic mutations increase hepatic clonal fitness and regeneration in chronic liver disease

Cell., 18 April 2019

Polyploidy spectrum: a new marker in HCC classification

Gut., 12 April 2019

p38γ is essential for cell cycle progression and liver tumorigenesis

Nature, 10 April 2019

Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

Lancet Gastroenterology & Hepatology, 3 April 2019

Adiponectin influences gender disparity in HCC

Journal of Experimental Medicine, 3 April 2019

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet Oncology, 18 January 2019

A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma

Journal of Hepatology, 14 January 2019

Sport decreases the risk of hepatocellular carcinoma

Journal of Hepatology, 21 December 2018

12 3 4 5 6 7 8 10

page 1 of 10

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search